Summary
IDEXX Laboratories, Inc. (IDXX) filed its 2011 10-K on February 16, 2012, providing a comprehensive overview of its business operations, financial condition, and strategic outlook. As a global leader in diagnostics and information technology for veterinarians, the company's performance is closely tied to the health of the companion animal market and the veterinary industry's adoption of advanced diagnostic tools. Investors should pay close attention to the company's revenue growth drivers, particularly within its key segments like Companion Animal Group and Water, where innovation and market penetration are crucial. The filing highlights the company's commitment to research and development, which fuels its product pipeline and competitive advantage. Management's Discussion and Analysis will likely offer insights into the company's financial performance, including revenue trends, profitability, and cash flow generation, alongside a discussion of the risks and uncertainties that could impact future results. Investors should review these sections carefully to understand the company's resilience and growth prospects in the dynamic animal health and laboratory diagnostics sectors.
Financial Highlights
52 data points| Revenue | $1.22B |
| Cost of Revenue | $572.18M |
| Gross Profit | $646.51M |
| R&D Expenses | $76.04M |
| Operating Income | $236.22M |
| Interest Expense | $3.55M |
| Net Income | $161.79M |
| EPS (Basic) | $1.43 |
| EPS (Diluted) | $1.39 |
| Shares Outstanding (Basic) | 113.58M |
| Shares Outstanding (Diluted) | 116.43M |
Key Highlights
- 1The 10-K report for the fiscal year ending December 30, 2011, was filed by IDEXX Laboratories, Inc. on February 16, 2012.
- 2The filing covers various aspects of the company's business, including its operations, financial health, risk factors, and corporate governance.
- 3Key sections such as 'Management's Discussion and Analysis of Financial Condition and Results of Operations' and 'Financial Statements and Supplementary Data' are crucial for understanding the company's performance.
- 4The report indicates that definitive proxy materials for the 2012 Annual Meeting, scheduled for May 9, 2012, will be incorporated by reference.
- 5IDEXX Laboratories operates in the animal health sector, providing veterinary diagnostics and information technology.
- 6Investors can find information on market performance, stockholder matters, and issuer purchases of equity securities in Item 5.